Copyright: ©Author(s) 2026.
World J Gastrointest Oncol. Mar 15, 2026; 18(3): 115664
Published online Mar 15, 2026. doi: 10.4251/wjgo.v18.i3.115664
Published online Mar 15, 2026. doi: 10.4251/wjgo.v18.i3.115664
Figure 1 Representative images of cells under a fluorescence microscope.
A: CD45(-), CEP8 > 2, circulating tumor cells (CTCs) positive; B: CD45(-), CEP17 > 2, CTCs positive; C: CD45(-), CEP8 > 2, CEP17 > 2, CTCs positive; D: CD45(+), CEP8 = 2, CEP17 = 2, CTCs negative.
Figure 2 Schematic diagram of recurrence and metastasis patterns in the circulating tumor cells-positive group.
A: Circulating tumor cells (CTCs)-negative group; B: CTCs-positive group. CTCs: Circulating tumor cells.
Figure 3 Comparison of progression-free survival and overall survival between circulating tumor cells-positive and circulating tumor cells-negative groups using the Kaplan-Meier method.
A: Progression-free survival; B: Overall survival. CTCs: Circulating tumor cells; PFS: Progression-free survival; OS: Overall survival.
- Citation: Chen QX, Zeng WM, Zhang YB, Cai YC, Lv CB, Sun YQ, Cai LS. Preoperative circulating tumor cells as a prognostic indicator in gastric cancer. World J Gastrointest Oncol 2026; 18(3): 115664
- URL: https://www.wjgnet.com/1948-5204/full/v18/i3/115664.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v18.i3.115664
